It is time to announce changes to the editorial board and other masthead groups. I would like to thank Bart Demaerschalk, Stefan Engelter, Max Findlay, Tudor Jovin, Helmi Lutsep, Salvador Pedraza, Lucas Restrepo, J. David Spence, Turgut Tatlisumak, and Salina Waddy for their service as editorial board members. I also thank Anne Abbott for her service as a section editor. Our new editorial board members are Karen Albright, Dominique Cadilhac, Rick Dijkhuzien, Hooman Kamel, Howard Kirschner, Gert Kwakkel, Glen Jickling, Bijoy Menon, Atte Meretoja, Alejandro Rabinstein, and Raymond Seet. Gary Ford is moving from the editorial board to become section coeditor for Prevention and Health Services Delivery. I would also like to thank Christopher S. Coffey, Yuko Y. Palesch, and Michael K. Parides for their service as consulting biostatisticians. The statistical reviews for Stroke are being reorganized under the leadership of Robert Goldberg, Statistical Coordinator, and an increasing number of statistical reviews of submitted articles are anticipated. To enhance the quality of meta-analyses submitted to Stroke, all of them will undergo a statistical review before acceptance. Stroke continues to be a healthy and vibrant contributor the medical literature with the help of all of our masthead members, and I thank them for the high-quality and timely article reviews, as well as their other contributions. I also thank the many others who perform reviews for Stroke for their time and efforts. Reviewer performance by nonboard member reviewers is the most important criteria used by the senior editors when new board members are chosen.
Stroke is a vibrant and increasingly influential journal. In calendar year 2015, there were >8.7 million full-article downloads of Stroke papers, a number supporting the status of Stroke as the leading source of information in the cerebrovascular field. Our most recent impact factor was that Stroke remains the second most highly cited journal among all peripheral vascular disease and clinical neurology journals. To date, in calendar year 2016, our acceptance rate for original research articles is 15.2%, and the time from acceptance to electronic and print publication are 34 and 57 days, respectively. It is truly an honor and privilege to serve as the Editor-in-Chief of this journal. I thank all of the authors, reviewers, readers, and masthead members for their contributions. I look forward to our continued interactions as we strive to enhance the quality and impact of Stroke in the continuing effort to improve the diagnostic capabilities, treatment, and prevention of the wide array of cerebrovascular disorders by using and disseminating the worldwide high-quality research conducted in the field.
The opinions expressed in this article are not necessarily those of the American Heart Association.
- © 2016 American Heart Association, Inc.